Well Referenced

Tag: postmenopausal women

The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women

A review published in The Journal of Sexual Medicine examined the role of testosterone therapy in managing hypoactive sexual desire disorder (HSDD) in postmenopausal women. The study found that testosterone treatment significantly improves sexual desire and satisfaction in this population. However, potential side effects such as hirsutism and acne were

Read More »
June 26, 2025 No Comments

The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study

A pilot study investigated the effects of hormone replacement therapy (HRT) on sleep-disordered breathing (SDB) in six postmenopausal women with mild to moderate SDB. Polysomnography was conducted at baseline, after 7-12 days of estrogen therapy, and again after an additional 7-13 days of combined estrogen and progesterone therapy. Estrogen alone

Read More »
June 26, 2025 No Comments

The influence of hormone replacement therapy on the aging-related change in cognitive performance. Analysis based on a Danish cohort study

This observational study examined the effects of hormone replacement therapy (HRT) on cognitive performance in postmenopausal women, analyzing data from the Danish MONICA study. It found that current users of HRT experienced less decline in concentration and visuomotor function compared to non-users. Women who started HRT during the study demonstrated

Read More »
June 26, 2025 No Comments

The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women

This review explores the efficacy and safety of testosterone therapy in treating hypoactive sexual desire disorder (HSDD) in postmenopausal women. Findings from large randomized, placebo-controlled trials indicate that transdermal testosterone significantly improves sexual desire, activity, and reduces distress related to sexual dysfunction. While most studies combined testosterone with estrogen/progesterone therapy,

Read More »
June 26, 2025 No Comments

The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society

This position statement by The North American Menopause Society (NAMS) evaluates the efficacy and safety of testosterone therapy in postmenopausal women, particularly for treating hypoactive sexual desire disorder (HSDD). Testosterone therapy has been associated with improvements in sexual desire, arousal, and satisfaction, though potential adverse effects include hirsutism, acne, and

Read More »
June 26, 2025 No Comments

The safety of oral versus transdermal estrogen

This observational study evaluates the safety differences between oral and transdermal estrogen therapy for managing menopausal symptoms. Findings suggest that transdermal estrogen has a more favorable safety profile, particularly in reducing the risk of venous thromboembolism (VTE) compared to oral estrogen, which increases VTE risk due to hepatic metabolism effects.

Read More »
June 26, 2025 No Comments